The Role of Hyperbaric Oxygen Therapy (HBOT) in Pain Management Clinics
Pain-management clinics may receive enquiries about hyperbaric oxygen therapy (HBOT), but it should not be presented as a standalone or universal answer to persistent pain. A responsible discussion starts with the person’s diagnosis, symptom pattern, current care plan and the clinical question being considered. In some pathways, a pressurised oxygen environment may be relevant to an underlying condition for which HBOT is considered; in others, the evidence does not support positioning it as a primary pain treatment.
The most appropriate service model is multidisciplinary. It places any chamber-based intervention alongside—not instead of—evidence-informed assessment, medication review where appropriate, movement and rehabilitation support, psychological approaches to pain, and specialist referral. Clear assessment, informed consent, safety checks and honest communication about likely benefits and limitations are essential to a patient-centred pain-management pathway.
Where HBOT May Be Considered
Consideration should begin with a clear diagnosis and a treatment plan led by appropriately qualified clinicians. The clinic should define the clinical context, screening criteria and referral arrangements rather than making broad claims about chronic pain, inflammation or recovery.
- Condition-specific assessment. The cause of pain and the person’s wider health needs guide care.
- Clear treatment objectives. Teams should agree measurable, realistic goals with the patient.
Integrated Pain Care
Multidisciplinary pathways
Services should coordinate with relevant medical, rehabilitation and psychological support.
Shared decision-making
Patients should receive balanced information on expected benefits, limitations, alternatives and potential risks.
Review of outcomes
Progress should be monitored against agreed functional outcomes, not assumed from treatment attendance alone.
Safety and Screening
HBOT requires a medical history, review of relevant conditions and medications, and screening for contraindications or precautions. Potential risks include pressure-related ear or sinus problems, temporary visual changes and confinement anxiety. New, severe or unexplained pain requires appropriate medical assessment.
Responsible Claims
Marketing should not imply that HBOT resolves chronic pain, replaces analgesia or guarantees symptom relief. A high-quality pain service is transparent about uncertainty, uses documented consent and keeps the focus on safe, coordinated care.
FAQs About HBOT in Pain Management Clinics
Services should have a clear clinical governance model, documented screening and consent processes, appropriately trained staff, emergency procedures, fire-safety controls and reliable communication with referrers. They should also avoid promising pain relief or functional improvement where this cannot be supported for the individual case.
It should sit alongside—not instead of—evidence-based options such as medication review, physical rehabilitation, psychological support, pacing, education and specialist referral where appropriate. Clear communication between the treating team and the chamber provider helps keep goals realistic, monitor response and preserve continuity of care.
Assessment should begin with the diagnosis, pain pattern, current treatment plan, functional goals, medication history and any red flags requiring medical review. The clinic should also consider suitability for a chamber environment, including relevant contraindications, ear and sinus health, informed consent and whether a referral to another specialist pathway is more appropriate.
Not as a universal or first-line treatment. The relevance of a hyperbaric oxygen environment depends on the underlying diagnosis and the clinical question being considered. Persistent pain should be assessed through an appropriate multidisciplinary pathway, with any chamber-based intervention considered only where clinically justified and never as a replacement for established pain management.
Frequently Asked Questions: HBOT in Pain Management Clinics
Is HBOT a proven treatment for all chronic pain?
No. HBOT should not be presented as a universal chronic-pain treatment. Its relevance, if any, depends on the diagnosed condition and an evidence-aware clinical assessment.
Can HBOT replace a pain-management plan?
No. It should not replace assessment, prescribed treatment, rehabilitation, psychological support or multidisciplinary pain care.
What should patients expect from an initial assessment?
They should expect a medical history, review of relevant risks and medications, discussion of alternatives and realistic treatment objectives.
Can HBOT be used alongside other care?
Where a clinician considers it appropriate, it should sit within a coordinated plan and not disrupt established treatment pathways.
Conclusion
Pain-management services considering HBOT should lead with diagnosis, safety, coordinated care and transparent communication—not broad or guaranteed claims of pain relief.